CASP8 and cancer: It has been reported that polymorphic variation in CASP8 influences cancer risk, such as the variant D302H (rs1045485), the 652 6N insertion/deletion (ins/del) promoter variant (rs3834129), and the IVS12-19G/A (rs3769818).